Press Room

Guy Villax speaker at PDA Quality Metrics & Quality Culture Conference

Start
Tuesday, February 21, 2017 - 07:15
End
Wednesday, February 22, 2017 - 17:15
Location: Bethesda, United States
Schedule meeting - PDA Quality Metrics & Quality Culture Conference| Hovione

Guy Villax will be speaking at the Quality Metrics & Quality Culture Conference in Bethesda, Maryland. The conference will have broad industry and academia participation.

Day 1 - 21 February 2017
10:45 AM – 11:45 AM

On day 1, Guy Villax will participate in a panel discussion about Perspectives on Quality Metrics and the FDA Proposal. This session explores benefits and challenges for implementing quality metrics programs. It will focus on the specific challenges posed by the new reissued guidance for various segments of the pharmaceutical industry and will cover proposed solutions to these challenges.

 

Day 2 - 22 February 2017
10:30 AM – 10:55 AM

On day 2, Guy Villax will be speaking on What Drives Quality Culture: A CEO's Perspective. This presentation is part of a session that brings to light what has executive management used to mobilize and dramatically improve a company’s quality culture?

 

Find more about Hovione's Quality Culture

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025